Prosecution Insights
Last updated: August 06, 2026

Silvia Salvadori, P.C.

43 pending office actions • 37 clients • 42 examiners • 25 art units • 0 of 43 (0%) have an AI response strategy ready

Quality Metrics (n=1028 apps, methodology: how we score firms)

83.0%
Allowance Rate
n=1028
+0.94σ
Allowance Rate (norm)
n=1028
3.9
OAs to Allowance
n=659
-0.13σ
OAs to Allow (norm)
n=659
1068 days
Time to Allowance
n=659
+16.1pp
Interview Lift
n=1028
34.5%
RCE Rate
n=1028
5.5%
Appeal Rate
n=1028

Rejection Performance (% of received rejections ultimately overcome)

79.7%
§101 Overcome
n=69
75.2%
§102 Overcome
n=258
72.2%
§103 Overcome
n=600
76.4%
§112 Overcome
n=526

Specialization & Scale

A61K, A61P, C07D
Top CPC Subclasses
43%
Top-3 CPC Share
n=1028
1
Practitioners
n=1028
1028.0
Apps / Practitioner
n=1028

Portfolio Summary

43
Total Pending OAs
26
Non-Final OAs
15
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

12
Overdue
2
Due this week
3
Due this month
2
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (12)Due ≤ 7 days (2)Due ≤ 30 days (3)Due ≤ 60 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

19
Hard (44%)
22
Medium (51%)
2
Easy (5%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (5%)
§103 only20 (47%)
§112 only1 (2%)
Double-patenting only1 (2%)
Double-patenting + other2 (5%)
Multi-statute (no §101)17 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

34
Life Sciences
79% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
5% of docket
7
Business / Other
16% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

430 h
Manual time on pending OAs
86 h
Time saved (low, 20%)
150 h
Time saved (mid, 35%)
3.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MACH, ANDRE 2 45.9% +53.2%
BEKKER, KELLY JO 1 16.6% +35.2%
ALAOUIE, ALI MUSTAFA 1
LEFF, STEVEN N 1 41.3% +7.9%
RAO, SAVITHA M 1 60.8% +29.7%
ARNOLD, ERNST V 1 48.1% +13.0%
ROBERTS, LEZAH 1 48.6% +35.6%
O'HERN, BRENT T 1 78.1% +20.2%
BAZARGANI, ARYA AHMADI 1 75.0% +37.5%
STEVENS, MARK V 1 65.4% +42.0%

Hard Cases (20)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18581508 COSMETIC METHOD FOR HAIR WITH OZONE LIU, SUE XU 77d overdue
18549941 VACCINE COMPOSITION COMPRISING A LEISHMANIA HOST CELL EXPRESSING AT LEAST ONE PROTEIN OF THE FAMILY CORONAVIRIDAE GRIZER, CASSANDRA SENN 31d overdue
18002897 COVALENTLY CROSS-LINKED GLYCOSYLATED MUCIN NANOPARTICLES AS SYSTEMS FOR THE DELIVERY AND RELEASE OF ACTIVE INGREDIENTS AND BIOMOLECULES HELM, CARALYNNE E 24d overdue
18253940 ANTI-CLIC1 PROTEIN ANTIBODIES AND THE DIAGNOSTIC AND THERAPEUTIC USES THEREOF SKOKO III, JOHN JOSEPH 18d overdue
18246607 RECOMBINANT YEAST FOR THE PRODUCTION OF OLIGOPEPTIDE NOAKES, SUZANNE MARIE 18d overdue
18568963 NON-INVASIVE DEVICE FOR QUICKLY ESTIMATING ANAEMIA BORISSOV, IGOR N 2d overdue
18245373 FERMENTED AVOCADO GRANULATE AND FOOD SUPPLEMENTS CONTAINING IT TIEN, LUCY MINYU 7d
17757455 SYNOVIAL FLUID SUBSTITUTES MACH, ANDRE 7d

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17757455 SYNOVIAL FLUID SUBSTITUTES MACH, ANDRE 7d
18580477 PHYTOTHERAPEUTIC COMPOSITIONS FOR ENDOTHERAPY MACH, ANDRE 20d
18863428 CONFECTIONERY PRODUCT RESISTANT TO HIGH TEMPERATURES BEKKER, KELLY JO
18835362 QUERCETIN-BASED COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF OCULAR AFFECTIONS RAO, SAVITHA M
18721678 METHOD FOR THE PREPARATION OF HYBRID POLYMERIC NANOPARTICLES FOR THE RELEASE OF OLIGONUCLEOTIDE DRUGS IN PHARMACOLOGICAL THERAPIES FOR REGENERATIVE, CURATIVE, AND PREVENTIVE PURPOSES ARNOLD, ERNST V
18718808 POWDERS FOR INHALATION AND PRODUCTION PROCESS THEREOF ROBERTS, LEZAH
18666909 LENTIL PASTA AND METHOD FOR ITS PREPARATION O'HERN, BRENT T
18709841 LIQUID COMPOSITION OF CERAMIDES AND PALMITIC ACID AMIDES BAZARGANI, ARYA AHMADI

Client Portfolio (37 clients)

Top Art Units

Art UnitApps
16154
17922
16132
16122
17932
16452
16162
16552
16562
17141

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18863428 CONFECTIONERY PRODUCT RESISTANT TO HIGH TEMPERATURES Perfetti Van Melle S.p.A. BEKKER, KELLY JO §103 Non-Final OA Pending Nov 06, 2024
18849545 TOPICAL PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY AND USES THEREOF Glycores 2000 Srl ALAOUIE, ALI MUSTAFA §103 Non-Final OA Pending Sep 23, 2024
18840081 A PROCESS FOR THE PRODUCTION OF A SOYBEAN FLOUR HAVING A HIGH SOLUBILITY La Sanfermese S.p.A. LEFF, STEVEN N 1792 §103 Non-Final OA Pending Aug 21, 2024
18835362 QUERCETIN-BASED COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF OCULAR AFFECTIONS Indena S.p.A. RAO, SAVITHA M DP Non-Final OA Pending Aug 02, 2024
18721678 METHOD FOR THE PREPARATION OF HYBRID POLYMERIC NANOPARTICLES FOR THE RELEASE OF OLIGONUCLEOTIDE DRUGS IN PHARMACOLOGICAL THERAPIES FOR REGENERATIVE, CURATIVE, AND PREVENTIVE PURPOSES UNIVERSITA' DEGLI STUDI DI TORINO ARNOLD, ERNST V 1613 §103 Non-Final OA Pending Jun 19, 2024
18718808 POWDERS FOR INHALATION AND PRODUCTION PROCESS THEREOF Azienda Ospedaliero-Universitaria Careggi ROBERTS, LEZAH 1612 §102§103 Non-Final OA Pending Jun 12, 2024
18666909 LENTIL PASTA AND METHOD FOR ITS PREPARATION Andriani S.p.A. O'HERN, BRENT T 1793 §103 Non-Final OA Pending May 17, 2024
18709841 LIQUID COMPOSITION OF CERAMIDES AND PALMITIC ACID AMIDES Unifarco S.p.A. BAZARGANI, ARYA AHMADI §101§102§103§112 Non-Final OA Pending May 14, 2024
18701691 EXTRACELLULAR VESICLES DERIVED FROM MILK AND PROCESS FOR ISOLATING THE SAME Evobiotix SA STEVENS, MARK V 1613 §103§112 Non-Final OA Pending Apr 16, 2024
18700724 LACTOBACILLUS STRAIN USABLE FOR STIMULATING AND REBALANCING INTESTINAL MICROBIOTA Alma Mater Studiorum - Universita' Di Bologna HAMA, JOANNE 1645 §101§102§103§112 Non-Final OA Pending Apr 12, 2024
18700010 DETERGENT COMPOSITION FOR INTERNAL PARTS OF VEHICLES Ma-Fra S.p.A. GOLIGHTLY, ERIC WAYNE 1714 §103 Final Rejection 26d overdue Pending Apr 10, 2024
18689987 COSMETIC METHOD FOR TREATING HAIR WITH OZONE Federico Montanari WORSHAM, JESSICA N 1615 §103Other Non-Final OA 3d overdue Pending Mar 07, 2024
18596842 POLYAMINOMETHYLENE PHOSPHONATE DERIVATIVES WITH LOW PHOSPHOROUS CONTENT HAVING SEQUESTERING AND DISPERSING PROPERTIES, RELATED USES AND PROCESSES FOR THE PREPARATION THEREOF Giovanni Bozzetto S.p.A. RHOADES, DEREK JAMES §103 Non-Final OA Pending Mar 06, 2024
18581508 COSMETIC METHOD FOR HAIR WITH OZONE Purò S.r.l. LIU, SUE XU 1616 §102§103§112Other Non-Final OA 77d overdue Pending Feb 20, 2024
18681188 PLATELETS TRANSFECTED WITH SIRNA AND THE THERAPEUTICS USES THEREOF Plasfer S.r.l. LIPPOLIS, ALEXANDRA ROSE 1653 §103§112 Non-Final OA Pending Feb 05, 2024
18290888 PHARMACEUTICAL OR FODD SUPPLEMENT FORMULATION CONTAINING ALPHA-LACTALBUMIN AND BUTYRIC ACID OR A SALT THEREOF Kolfarma S.r.l. TRUONG, QUANGLONG N §103 Non-Final OA Pending Jan 22, 2024
18580477 PHYTOTHERAPEUTIC COMPOSITIONS FOR ENDOTHERAPY Ndg Natural Development Group S.r.l. MACH, ANDRE 1615 §103§112 Non-Final OA 20d Pending Jan 18, 2024
18579158 USE OF LACTOBACILLUS PARACASEI BACTERIAL STRAINS IN THE TREATMENT OF NEWBORNS Alfasigma S.p.A. CHHAY, BONIRATH 1645 §103§112DP Final Rejection 2d overdue Pending Jan 12, 2024
18576132 STAINING COMPOSITIONS FOR BIOLOGICAL, CYTOLOGICAL, HISTOLOGICAL AND AUTOPSICAL SAMPLES Diapath S.p.A. KASS, BENJAMIN JOSEPH §103 Non-Final OA Pending Jan 03, 2024
18568963 NON-INVASIVE DEVICE FOR QUICKLY ESTIMATING ANAEMIA UNIVERSITA' DEGLI STUDI DI BARI ALDO MORO BORISSOV, IGOR N 3685 §102§103 Final Rejection 2d overdue Pending Dec 11, 2023
18565715 OILY FORMULATIONS OF CANNABINOIDS VELLEJA RESEARCH S.R.L. BOECKELMAN, JACOB A 1655 §103 Final Rejection Pending Nov 30, 2023
18493221 USE OF A COMPOSITION COMPRISING MICROORGANISMS TO INCREASE THE INTESTINAL PRODUCTION OF BUTYRIC ACID, FOLIC ACID OR NIACIN AND/OR DECREASE THE INTESTINAL PRODUCTION OF SUCCINIC ACID Alfasigma S.p.A. XU, QING 1656 §103 Final Rejection 63d Pending Oct 24, 2023
18556691 FUSION PROTEINS AND USE THEREOF IN THE TREATMENT OF MEMBRANOUS NEPHROPATHY Kilometro Rosso Spa MCCOLLUM, ANDREA K 1674 §103§112 Non-Final OA Pending Oct 23, 2023
18552694 DIGITAL INKJET PRINTING PRIMER FOR PLASTIC FILMS FOR FOOD PACKAGING Goglio S.p.A. HON, SOW FUN 1782 §103 Non-Final OA 40d Pending Sep 27, 2023
18549941 VACCINE COMPOSITION COMPRISING A LEISHMANIA HOST CELL EXPRESSING AT LEAST ONE PROTEIN OF THE FAMILY CORONAVIRIDAE Vismederi S.r.l. (10%) GRIZER, CASSANDRA SENN 1672 §103§112 Non-Final OA 31d overdue Pending Sep 11, 2023
18448306 SYSTEM AND METHOD FOR SCORING AND/OR CUTTING CHEWING GUM Perfetti Van Melle Benelux BV CROSBY JR, RICHARD D 3724 §103 Non-Final OA Pending Aug 11, 2023
18254864 SOLUBLE POLYELECTROLYITIC COMPLEXES OF POLYMERIC BIGUANIDINE MICROBIOCIDES WITH GLYCOSAMINOGLYCANS Altergon S.A. LIU, TRACY 1614 §103§112 Final Rejection 41d Pending May 29, 2023
18253940 ANTI-CLIC1 PROTEIN ANTIBODIES AND THE DIAGNOSTIC AND THERAPEUTIC USES THEREOF UNIVERSITA' DEGLI STUDI DI MILANO SKOKO III, JOHN JOSEPH 1643 §102§103§112 Non-Final OA 18d overdue Pending May 23, 2023
18249000 CONFECTIONERY PRODUCT Perfetti Van Melle S.p.A. HAWKINS, AMANDA SALATA 1793 §103 Non-Final OA 86d overdue Pending Apr 13, 2023
18246607 RECOMBINANT YEAST FOR THE PRODUCTION OF OLIGOPEPTIDE Lesaffre Et Compagnie NOAKES, SUZANNE MARIE 1656 §103§112 Final Rejection 18d overdue Pending Mar 24, 2023
18245373 FERMENTED AVOCADO GRANULATE AND FOOD SUPPLEMENTS CONTAINING IT Pecten Group S.r.l. TIEN, LUCY MINYU 1612 §103§112 Final Rejection 7d Pending Mar 15, 2023
18022088 THERAPEUTIC COMBINATION FOR THE TREATMENT OF BREAST CANCER UNIVERSITA DEGLI STUDI DE GENOVA DAHLIN, HEATHER RAQUEL 1629 §103Other Non-Final OA Pending Feb 17, 2023
18002897 COVALENTLY CROSS-LINKED GLYCOSYLATED MUCIN NANOPARTICLES AS SYSTEMS FOR THE DELIVERY AND RELEASE OF ACTIVE INGREDIENTS AND BIOMOLECULES Politecnico Di Milano HELM, CARALYNNE E 1615 §103§112 Final Rejection 24d overdue Pending Dec 22, 2022
17999906 AQUEOUS DESINFECTANT COMPOSITION FOR GLASSES Unifarco S.p.A. WISTNER, SARAH CLINKSCALES 1616 §112 Final Rejection 23d Pending Nov 25, 2022
17998534 COMPOSITION COMPRISING METHYLFOLATE Alfasigma S.p.A. KASSA, TIGABU 1619 §103§112 Non-Final OA Pending Nov 11, 2022
17905646 BLOOD PREPARATION USEFUL FOR WOUND HEALING AND TISSUE REGENERATION Novystem S.p.A. MELLER, MICHAEL V 1655 §103 Final Rejection 78d overdue Pending Sep 05, 2022
17757455 SYNOVIAL FLUID SUBSTITUTES Altergon S.A. MACH, ANDRE 1615 §102§103 Final Rejection 7d Pending Jun 16, 2022
17756908 NEW STRAINS OF LACTIC ACID BACTERIA, FOOD COMPOSITION COMPRISING THEM, PREPARATION OF SUCH COMPOSITION Celery S.r.l. DAVIS, RUTH A 1699 §103 Final Rejection 5d overdue Pending Jun 06, 2022
17755319 CONFECTIONARY PRODUCT FOR INSTANT OPTICAL TOOTH WHITENING Perfetti Van Melle S.p.A. AXTELL, ASHLEY 1792 §103§112 Non-Final OA Pending Apr 27, 2022
17628578 PROCESS FOR THE PREPARATION OF AMORPHOUS MIDOSTAURIN WITH A LOW CONTENT OF RESIDUAL ORGANIC SOLVENT Procos S.p.A. ADLAM, CHANTAL PETA-GAYE 1622 §103 Non-Final OA 30d Pending Jan 20, 2022
17618906 COMPOUND AND COMPOSITIONS FOR MULTITARGET TREATMENT OF TAU PROTEIN-RELATED DISORDERS Fondazione Irccs Istituto Neurologico Carlo Besta REYNOLDS, FRED H 1658 §103§112 Final Rejection Pending Dec 14, 2021
17425012 A COMPOSITION FOR THE TREATMENT OF PERIODONTITIS AND REGENERATION OF INTERDENTAL PAPILLA Mastelli S.r.l. KIM, TAEYOON 1631 §103 Non-Final OA Pending Jul 22, 2021
17295722 MULTI-LAYERED PARTICLES Sphera Encapsulation Srl HOERNER, PAUL ELLSWORTH 1611 §103DP Final Rejection Pending May 20, 2021

Managing Silvia Salvadori, P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month